Schmandt RE - Search Results

1

The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.

Schmandt RE, Bennett M, Clifford S, Thornton A, Jiang F, Broaddus RR, Sun CC, Lu KH, Sood AK, Gershenson DM. Schmandt RE, et al. Cancer Biol Ther. 2006 Sep;5(9):1136-41. doi: 10.4161/cbt.5.9.2953. Epub 2006 Sep 28. Cancer Biol Ther. 2006. PMID: 16855388 Free article.

2

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.

Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM. Schmandt RE, et al. Cancer. 2003 Aug 15;98(4):758-64. doi: 10.1002/cncr.11561. Cancer. 2003. PMID: 12910520 Free article.

3

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.

Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM. Wong KK, et al. Among authors: schmandt re. Int J Gynecol Pathol. 2007 Oct;26(4):404-9. doi: 10.1097/pgp.0b013e31803025cd. Int J Gynecol Pathol. 2007. PMID: 17885490

4

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

5

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

6

Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.

Merritt WM, Thaker PH, Landen CN Jr, Deavers MT, Fletcher MS, Lin YG, Han LY, Kamat AA, Schmandt R, Gershenson DM, Kinch MS, Sood AK. Merritt WM, et al. Cancer Biol Ther. 2006 Oct;5(10):1357-60. doi: 10.4161/cbt.5.10.3225. Epub 2006 Oct 31. Cancer Biol Ther. 2006. PMID: 16969087 Free article.

7

Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.

Landen CN, Merritt WM, Mangala LS, Sanguino AM, Bucana C, Lu C, Lin YG, Han LY, Kamat AA, Schmandt R, Coleman RL, Gershenson DM, Lopez-Berestein G, Sood AK. Landen CN, et al. Cancer Biol Ther. 2006 Dec;5(12):1708-13. doi: 10.4161/cbt.5.12.3468. Epub 2006 Dec 30. Cancer Biol Ther. 2006. PMID: 17106249 Free article.

8

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.

Lu C, Bonome T, Li Y, Kamat AA, Han LY, Schmandt R, Coleman RL, Gershenson DM, Jaffe RB, Birrer MJ, Sood AK. Lu C, et al. Cancer Res. 2007 Feb 15;67(4):1757-68. doi: 10.1158/0008-5472.CAN-06-3700. Cancer Res. 2007. PMID: 17308118

9

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Co NN, Iglesias D, Celestino J, Kwan SY, Mok SC, Schmandt R, Lu KH. Co NN, et al. Cancer. 2014 Nov 15;120(22):3457-68. doi: 10.1002/cncr.28854. Epub 2014 Jul 16. Cancer. 2014. PMID: 25042259 Free PMC article.

10

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.

Jazaeri AA, Lu K, Schmandt R, Harris CP, Rao PH, Sotiriou C, Chandramouli GV, Gershenson DM, Liu ET. Jazaeri AA, et al. Mol Carcinog. 2003 Feb;36(2):53-9. doi: 10.1002/mc.10098. Mol Carcinog. 2003. PMID: 12557260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters